Ablation catheter

DEVICE4 trials

Sponsors

Tomonobu Koizumi, The Leeds Teaching Hospitals NHS Trust, Novosibirsk Scientific Research Institute for Circulatory Pathology, I-Med-Pro GmbH

Conditions

Atrial FlutterChronic Thromboembolic Pulmonary HypertensionParoxysmal Atrial Fibrillationlung cancer

Phase 2

Interventional Treatment of Residual Pulmonary Hypertension in Patients After Pulmonary Thromboendarterectomy

Novosibirsk Scientific Research Institute for Circulatory PathologyChronic Thromboembolic Pulmonary Hypertension

Start: 2015-08-31End: 2017-02-28Target: 50Updated: 2016-06-03

Unknown Phase

ablation therapy for early peripheral lung cancer using ablation catheter under bronchoscopy

RecruitingJPRN-UMIN000003285

Tomonobu Koizumilung cancer

Start: 2010-04-01Target: 30Updated: 2026-06-29

The VERISMART Trial

CompletedNCT02490033

The Leeds Teaching Hospitals NHS TrustAtrial Flutter

Start: 2015-04-01End: 2018-10-28Updated: 2019-08-08

CardioFocus vs. Contact Force Guided Pulmonary Vein Isolation in Paroxysmal Atrial Fibrillation

CompletedNCT03056222

I-Med-Pro GmbHParoxysmal Atrial Fibrillation

Start: 2017-04-10End: 2021-11-15Updated: 2021-11-19

Related Papers

4282Pulmonary artery denervation in patients with residual pulmonary hypertension after pulmonary endarterectomy: one-year results of the first -in-man, sham-controlled, pilot randomized clinical trial

European Heart Journal2019-10-01

Multicentre randomised trial comparing contact force with electrical coupling index in atrial flutter ablation (VERISMART trial)

PLoS ONE2019-04-039 citations